Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02135692
Brief Title: A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

First Submitted : May 8, 2014
First Submitted that Met QC Criteria : May 8, 2014
First Posted : May 12, 2014 (Estimate)

Results First Submitted : March 29, 2018
Results First Submitted that Met QC Criteria : March 29, 2018
Results First Posted : May 2, 2018

Last Update Submitted that Met QC Criteria : November 19, 2019
Last Update Posted : December 3, 2019